Ase Technology Holding Q2 Pretax Profit Twd 9255 Million

TAIPEI, July 31, 2025 /PRNewswire/ — ASE Technology Holding Co., Ltd. (, ) ("We", "ASEH", or the "Company"), the leading provider of semiconductor assembly and testing services ("ATM") and the provider of electronic manufacturing services ("EMS"), today reported its unaudited([1]) net revenues of NT$150,750 million for 2Q25, up by 7.5% year-over-year and up by 1.8% sequentially. Net income attributable to shareholders of the parent for the quarter totaled NT$7,521 million, down from NT$7,778 million in 2Q24 and down from NT$7,554 million in 1Q25. Basic earnings per share for the quarter were NT$1.74 (or US$0.111 per ADS), compared to NT$1.80 for 2Q24 and NT$1.75 for 1Q25. Diluted earnings per share for the quarter were NT$1.70 (or US$0.109 per ADS), compared to NT$1.75 for 2Q24 and NT$1.64 for 1Q25.

RESULTS OF OPERATIONS

2Q25 Results Highlights — Consolidated

• Net revenues from packaging operations, testing operations, EMS operations, and others represented approximately 49%, 11%, 39%, and 1% of the total net revenues for the quarter, respectively.
• Cost of revenues was NT$125,063 million for the quarter, up from NT$123,260 million in 1Q25.- Raw material cost totaled NT$71,321 million for the quarter, representing 47% of the total net revenues.- Labor cost totaled NT$17,995 million for the quarter, representing 12% of the total net revenues.- Depreciation, amortization and rental expenses totaled NT$15,183 million for the quarter.
• Gross margin increased by 0.2 percentage points to 17.0% in 2Q25 from 16.8% in 1Q25.
• Operating margin was 6.8% in 2Q25, compared to 6.5% in 1Q25.
• In terms of non-operating items:- Net interest expense was NT$1,203 million.- Net foreign exchange gain was NT$11,885 million, primarily attributable to the depreciation of the U.S. dollar against the New Taiwan dollar.- Net loss on valuation of financial assets and liabilities was NT$12,098 million.- Net gain on equity-method investments was NT$223 million.- Other net non-operating income was NT$255 million, primarily attributable to miscellaneous income.Total non-operating expenses for the quarter were NT$938 million.
• Income before tax was NT$9,255 million in 2Q25, compared to NT$9,810 million in 1Q25. We recorded income tax expenses of NT$1,576 million for the quarter, compared to NT$2,022 million in 1Q25.
• Net income attributable to shareholders of the parent was NT$7,521 million in 2Q25, compared to NT$7,778 million in 2Q24 and NT$7,554 million in 1Q25.
• Our total number of shares outstanding at the end of the quarter was 4,422,175,232, including treasury stock owned by our subsidiaries in 2Q25. Our 2Q25 basic earnings per share of NT$1.74 (or US$0.111 per ADS) were based on 4,332,918,727 weighted average number of shares outstanding in 2Q25. Our 2Q25 diluted earnings per share of NT$1.70 (or US$0.109 per ADS) were based on 4,395,186,708 weighted average number of shares outstanding in 2Q25.

2Q25 Results Highlights — ATM

• Net revenues were NT$92,565 million for the quarter, up by 19.0% year-over-year and up by 6.8% sequentially.
• Cost of revenues was NT$72,317 million for the quarter, up by 19.3% year-over-year and up by 7.8% sequentially.- Raw material cost totaled NT$26,338 million for the quarter, representing 29% of the total net revenues.- Labor cost totaled NT$14,606 million for the quarter, representing 16% of the total net revenues.- Depreciation, amortization and rental expenses totaled NT$13,822 million for the quarter.
• Gross margin decreased by 0.7 percentage points to 21.9% in 2Q25 from 22.6% in 1Q25.
• Operating margin was 9.5% in 2Q25, compared to 9.6% in 1Q25.

2Q25 Results Highlights — EMS

• Net revenues were NT$58,770 million, down by 6.6% year-over-year and down by 5.7% sequentially.
• Cost of revenues for the quarter was NT$53,221 million, down by 6.4% year-over-year and down by 6.2% sequentially.- Raw material cost totaled NT$45,277 million for the quarter, representing 77% of the total net revenues.- Labor cost totaled NT$3,283 million for the quarter, representing 6% of the total net revenues.- Depreciation, amortization and rental expenses totaled NT$1,110 million for the quarter.
• Gross margin increased by 0.5 percentage points to 9.4% in 2Q25 from 8.9% in 1Q25.
• Operating margin was 2.6% in both 2Q25 and 1Q25.

LIQUIDITY AND CAPITAL RESOURCES

• Equipment capital expenditures in 2Q25 totaled US$992 million, of which US$690 million was used in packaging operations, US$251 million in testing operations, US$49 million in EMS operations and US$2 million in interconnect materials operations and others.
• Total unused credit lines amounted to NT$355,299 million as of June 30, 2025.
• Current ratio was 1.02 and net debt to equity ratio was 0.52 as of June 30, 2025.
• Total number of employees was 100,450 as of June 30, 2025, compared to 96,436 as of March 31, 2025.

Business Review

Customers

ATM Basis

• Our five largest customers together accounted for approximately 43% of our total net revenues in 2Q25, compared to 44% in 1Q25. One customer accounted for more than 10% of our total net revenues in 2Q25.
• Our top 10 customers contributed 60% of our total net revenues in 2Q25, compared to 61% in 1Q25.
• Our customers that are integrated device manufacturers or IDMs accounted for 35% of our total net revenues in 2Q25, compared to 34% in 1Q25.

EMS Basis

• Our five largest customers together accounted for approximately 65% of our total net revenues in 2Q25, compared to 68% in 1Q25. One customer accounted for more than 10% of our total net revenues in 2Q25.
• Our top 10 customers contributed 71% of our total net revenues in 2Q25, compared to 74% in 1Q25.

About ASE Technology Holding Co., Ltd.

ASEH is the leading provider of semiconductor manufacturing services in assembly and test. The Company develops and offers complete turnkey solutions covering front-end engineering test, wafer probing and final test, as well as packaging, materials and electronic manufacturing services through USI with superior technologies, breakthrough innovations, and advanced development programs. With advanced technological capabilities and a global presence spanning Taiwan, China, South Korea, Japan, Singapore, Malaysia, Philippines, Vietnam, Mexico, and Tunisia as well as the United States and Europe, ASEH has established a reputation for reliable, high quality products and services.

For more information, please visit our website at https://www.aseglobal.com.

Safe Harbor Notice

This press release contains "forward-looking statements" within the meaning of Section 27A of the United States Securities Act of 1933, as amended, and Section 21E of the United States Securities Exchange Act of 1934, as amended. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. Although these forward-looking statements, which may include statements regarding our future results of operations, financial condition or business prospects, are based on our own information and information from other sources we believe to be reliable, you should not place undue reliance on these forward-looking statements, which apply only as of the date of this press release. The words "anticipate," "believe," "estimate," "expect," "intend," "plan" and similar expressions, as they relate to us, are intended to identify these forward-looking statements in this press release. These forward-looking statements are necessarily estimates reflecting the best judgment of our senior management and our actual results of operations, financial condition or business prospects may differ materially from those expressed or implied by the forward-looking statements for reasons including, among others, risks associated with cyclicality and market conditions in the semiconductor or electronic industry; changes in our regulatory environment, including our ability to comply with new or stricter environmental regulations and to resolve environmental liabilities; demand for the outsourced semiconductor packaging, testing and electronic manufacturing services we offer and for such outsourced services generally; the highly competitive semiconductor or manufacturing industry we are involved in; our ability to introduce new technologies in order to remain competitive; international business activities; our business strategy; our future expansion plans and capital expenditures; the strained relationship between the Republic of China and the People's Republic of China; general economic and political conditions; the recent shift in United States trade policies; possible disruptions in commercial activities caused by natural or human-induced disasters; fluctuations in foreign currency exchange rates; and other factors. For a discussion of these risks and other factors, please see the documents we file from time to time with the Securities and Exchange Commission, including the 2024 Annual Report on Form 20-F filed on March 27, 2025.

Supplemental Financial Information

(Unaudited)

Consolidated Operations

 
                             2Q25    1Q25    2Q24 
--------------------------  ------  ------  ------ 
EBITDA([2]) (NT$ million)   27,426  27,628  26,127 
--------------------------  ------  ------  ------ 
 

ATM Operations

 
                                 2Q25    1Q25    2Q24 
------------------------------  ------  ------  ------ 
Net Revenues (NT$ million)      92,565  88,668  77,813 
------------------------------  ------  ------  ------ 
Revenues by Application 
------------------------------  ------  ------  ------ 
Communication                     46 %    48 %    49 % 
------------------------------  ------  ------  ------ 
Computing                         24 %    22 %    19 % 
------------------------------  ------  ------  ------ 
Automotive, Consumer & Others     30 %    30 %    32 % 
------------------------------  ------  ------  ------ 
Revenues by Type 
------------------------------  ------  ------  ------ 
Bumping, Flip Chip, WLP & SiP     47 %    46 %    44 % 
------------------------------  ------  ------  ------ 
Wirebonding                       28 %    28 %    31 % 
------------------------------  ------  ------  ------ 
Others                             5 %     6 %     7 % 
------------------------------  ------  ------  ------ 
Testing                           18 %    18 %    16 % 
------------------------------  ------  ------  ------ 
Material                           2 %     2 %     2 % 
------------------------------  ------  ------  ------ 
Capacity & EBITDA 
------------------------------  ------  ------  ------ 
Equipment CapEx (US$ million)      942     869     374 
------------------------------  ------  ------  ------ 
EBITDA([2]) (NT$ million)       24,295  24,146  22,205 
------------------------------  ------  ------  ------ 
Number of Wirebonders           25,156  25,222  25,154 
------------------------------  ------  ------  ------ 
Number of Testers                6,797   6,686   5,676 
------------------------------  ------  ------  ------ 
 

EMS Operations

 
                                 2Q25    1Q25    2Q24 
------------------------------  ------  ------  ------ 
Net Revenues (NT$ million)      58,770  62,295  62,907 
                                ------  ------  ------ 
Revenues by Application 
------------------------------  ------  ------  ------ 
Communication                     33 %    33 %    33 % 
------------------------------  ------  ------  ------ 
Computing                         11 %    11 %    11 % 
------------------------------  ------  ------  ------ 
Consumer                          30 %    31 %    29 % 
------------------------------  ------  ------  ------ 
Industrial                        14 %    13 %    13 % 
------------------------------  ------  ------  ------ 
Automotive                        10 %    10 %    11 % 
------------------------------  ------  ------  ------ 
Others                             2 %     2 %     3 % 
------------------------------  ------  ------  ------ 
Capacity 
------------------------------  ------  ------  ------ 
Equipment CapEx (US$ million)       49      23      31 
------------------------------  ------  ------  ------ 
 

ASE Technology Holding Co., Ltd.

Summary of Consolidated Statement of Income Data

(In NT$ million, except per share data)

(Unaudited)

 
                        For the three months ended           For the six months ended 
                  ======================================  ============================== 
                                          Jun. 30 2024                 Jun. 30 2024 
                   Jun. 30    Mar. 31   (Retrospectively   Jun. 30   (Retrospectively 
                     2025       2025       Adjusted)         2025        Adjusted) 
Net revenues 
 Packaging           73,659     68,411            62,834    142,070            122,292 
 Testing             16,612     16,004            12,623     32,616             24,725 
 EMS                 58,374     61,860            62,853    120,234            122,179 
 Others               2,105      1,878             1,928      3,983              3,845 
                                                          ---------  ----------------- 
Total net 
 revenues           150,750    148,153           140,238    298,903            273,041 
                  ---------  ---------  ----------------  ---------  ----------------- 
 
Cost of revenues  (125,063)  (123,260)         (117,184)  (248,323)          (229,166) 
                                                          ---------  ----------------- 
Gross profit         25,687     24,893            23,054     50,580             43,875 
                  ---------  ---------  ----------------  ---------  ----------------- 
 
Operating 
expenses 
 Research and 
  development       (8,004)    (7,579)           (7,106)   (15,583)           (13,715) 
 Selling, 
  general and 
  administrative    (7,490)    (7,643)           (6,939)   (15,133)           (13,674) 
                                                          ---------  ----------------- 
 Total operating 
  expenses         (15,494)   (15,222)          (14,045)   (30,716)           (27,389) 
                                                          ---------  ----------------- 
Operating income     10,193      9,671             9,009     19,864             16,486 
                  ---------  ---------  ----------------  ---------  ----------------- 
 
Net 
non-operating 
income and 
expenses 
 Interest 
  expense - net     (1,203)    (1,256)           (1,158)    (2,459)            (2,265) 
 Foreign 
  exchange gain 
  (loss) - net       11,885    (1,675)           (1,420)     10,210            (4,639) 
 Gain (Loss) on 
  valuation of 
  financial 
  assets  and 
  liabilities - 
  net              (12,098)      2,873             2,664    (9,225)              6,762 
 Gain on 
  equity-method 
  investments - 
  net                   223         40               459        263                516 
 Others - net           255        157               551        412              1,057 
                             ---------                    ---------  ----------------- 
 Total 
  non-operating 
  income and 
  expenses            (938)        139             1,096      (799)              1,431 
                  ---------  ---------  ----------------  ---------  ----------------- 
Income before 
 tax                  9,255      9,810            10,105     19,065             17,917 
 
Income tax 
 expense            (1,576)    (2,022)           (1,950)    (3,598)            (3,843) 
                  ---------  ---------  ----------------  ---------  ----------------- 
Income from 
 operations and 
 before non- 
  controlling 
 interests            7,679      7,788             8,155     15,467             14,074 
Non-controlling 
 interests            (158)      (234)             (377)      (392)              (636) 
                  ---------  ---------  ----------------  ---------  ----------------- 
 
Net income 
 attributable to 
 shareholders of 
  the parent          7,521      7,554             7,778     15,075             13,438 
                  =========  =========  ================  =========  ================= 
 
Per share data: 
Earnings per 
share 
 -- Basic           NT$1.74    NT$1.75           NT$1.80    NT$3.48            NT$3.11 
 -- Diluted         NT$1.70    NT$1.64           NT$1.75    NT$3.34            NT$3.01 
 
Earnings per 
equivalent ADS 
 -- Basic          US$0.111   US$0.106          US$0.112   US$0.218           US$0.196 
 -- Diluted        US$0.109   US$0.100          US$0.109   US$0.209           US$0.190 
 
Number of 
 weighted 
 average shares 
 used in 
  diluted EPS 
 calculation ( 
 in thousand 
 shares)          4,395,187  4,410,238         4,383,325  4,406,107          4,376,301 
 
FX (NTD/USD)          31.18      32.79             32.23      31.99              31.77 
 

ASE Technology Holding Co., Ltd.

Summary of ATM Statement of Income Data

(In NT$ million)

(Unaudited)

 
                                                  For the six months 
                   For the three months ended           ended 
                  ============================  ====================== 
                  Jun. 30   Mar. 31   Jun. 30    Jun. 30    Jun. 30 
                    2025      2025      2024       2025       2024 
Net revenues: 
 Packaging          74,440    69,360    63,838    143,800    124,226 
 Testing            16,612    16,004    12,623     32,616     24,725 
 Direct Material     1,431     1,219     1,264      2,650      2,602 
 Others                 82        85        88        167        168 
Total net 
 revenues           92,565    86,668    77,813    179,233    151,721 
                  --------  --------  --------  ---------  --------- 
 
Cost of revenues  (72,317)  (67,057)  (60,612)  (139,374)  (118,963) 
                                                ---------  --------- 
Gross profit        20,248    19,611    17,201     39,859     32,758 
                  --------  --------  --------  ---------  --------- 
 
Operating 
expenses: 
 Research and 
  development      (6,320)   (6,043)   (5,483)   (12,363)   (10,618) 
 Selling, 
  general and 
  administrative   (5,111)   (5,233)   (4,464)   (10,344)    (8,809) 
                                                ---------  --------- 
 Total operating 
  expenses        (11,431)  (11,276)   (9,947)   (22,707)   (19,427) 
                                                ---------  --------- 
Operating income     8,817     8,335     7,254     17,152     13,331 
                  --------  --------  --------  ---------  --------- 
 

ASE Technology Holding Co., Ltd.

Summary of EMS Statement of Income Data

(In NT$ million) (Unaudited)

 
                       For the three months ended         For the six months ended 
                  ====================================  ============================= 
                                        Jun. 30 2024                 Jun. 30 2024 
                  Jun. 30   Mar. 31   (Retrospectively   Jun. 30   (Retrospectively 
                    2025      2025       Adjusted)         2025       Adjusted) 
 
Net revenues        58,770    62,295            62,907    121,065           122,272 
                  --------  --------  ----------------  ---------  ---------------- 
 
Cost of revenues  (53,221)  (56,767)          (56,882)  (109,988)         (110,795) 
                                                        ---------  ---------------- 
Gross profit         5,549     5,528             6,025     11,077            11,477 
                  --------  --------  ----------------  ---------  ---------------- 
 
Operating 
expenses 
 Research and 
  development      (1,723)   (1,580)           (1,668)    (3,303)           (3,201) 
 Selling, 
  general and 
  administrative   (2,313)   (2,340)           (2,415)    (4,653)           (4,724) 
                                                        ---------  ---------------- 
 Total operating 
  expenses         (4,036)   (3,920)           (4,083)    (7,956)           (7,925) 
                                                        ---------  ---------------- 
Operating income     1,513     1,608             1,942      3,121             3,552 
                  --------  --------  ----------------  ---------  ---------------- 
 

ASE Technology Holding Co., Ltd.

Summary of Consolidated Balance Sheet Data

(In NT$ million)

(Unaudited)

 
                              As of Jun. 30, 2025  As of Mar. 31, 2025 
                              ===================  =================== 
Current assets 
 Cash and cash equivalents                 72,785               77,100 
 Financial assets -- current                4,118               16,435 
 Trade receivables                        103,101              109,717 
 Inventories                               57,058               59,858 
 Others                                    16,933               15,542 
                              -------------------  ------------------- 
Total current assets                      253,995              278,652 
 
Financial assets - 
 non-current & investments - 
 equity -method                            38,409               41,428 
Property, plant and 
 equipment                                364,849              342,056 
Right-of-use assets                        11,721               11,754 
Intangible assets                          65,610               66,955 
Others                                     30,591               33,332 
                              -------------------  ------------------- 
Total assets                              765,175              774,177 
                              ===================  =================== 
 
Current liabilities 
 Short-term borrowings([3])                40,369               55,485 
 Long-term debts - current 
  portion                                  12,930               20,774 
 Trade payables                            70,518               74,382 
 Others                                   125,153              117,101 
                              -------------------  ------------------- 
Total current liabilities                 248,970              267,742 
 
Bonds payable                              16,668               21,066 
Long-term borrowings([3])                 162,326              126,708 
Other liabilities                          22,276               23,638 
                              -------------------  ------------------- 
Total liabilities                         450,240              439,154 
 
Equity attributable to 
 shareholders of the parent               293,770              311,522 
Non-controlling interests                  21,165               23,501 
                              -------------------  ------------------- 
Total liabilities & 
 shareholders' equity                     765,175              774,177 
                              ===================  =================== 
 
 
Current ratio                                1.02                 1.04 
Net debt to equity ratio                     0.52                 0.41 
 

ASE Technology Holding Co., Ltd.

Summary of Consolidated Statement of Cash Flow Data

(In NT$ million)

(Unaudited)

 
                         For the three months ended         For the six months ended 
                    ====================================  ============================ 
                    Jun. 30   Mar. 31       Jun. 30       Jun. 30       Jun. 30 
                      2025      2025          2024          2025          2024 
                                        (Retrospectively            (Retrospectively 
                                            Adjusted)                   Adjusted) 
Cash Flows from 
Operating 
Activities: 
 Profit before 
  income tax           9,255     9,810            10,105    19,065            17,917 
 Depreciation & 
  amortization        16,531    16,092            14,813    32,623            29,412 
 Other operating 
  activities 
  items               11,059   (5,929)           (8,132)     5,130          (13,849) 
                    --------  --------  ----------------  --------  ---------------- 
Net cash generated 
 from operating 
  activities          36,845    19,973            16,786    56,818            33,480 
                    --------  --------  ----------------  --------  ---------------- 
Cash Flows from 
Investing 
Activities: 
 Net payments for 
  property, plant 
   and equipment    (43,104)  (36,349)          (14,786)  (79,453)          (27,299) 
 Other investment 
  activities 
  items                (469)   (1,212)               304   (1,681)           (2,690) 
Net cash used in 
 investing 
 activities         (43,573)  (37,561)          (14,482)  (81,134)          (29,989) 
                    --------  --------  ----------------  --------  ---------------- 
Cash Flows from 
Financing 
Activities: 
 Total net 
  proceeds from 
   (repayment of) 
  borrowings and 
   bonds              22,159    16,149          (12,330)    38,308          (12,470) 
 Other financing 
  activities 
  items                (662)       262           (1,093)     (400)           (1,126) 
Net cash generated 
 from (used in) 
  financing 
 activities           21,497    16,411          (13,423)    37,908          (13,596) 
                    --------  --------  ----------------  --------  ---------------- 
Foreign currency 
 exchange effect    (19,084)     1,784             2,187  (17,300)             8,994 
                    --------  --------  ----------------  --------  ---------------- 
Net increase 
 (decrease) in 
 cash and  cash 
 equivalents         (4,315)       607           (8,932)   (3,708)           (1,111) 
                    --------  --------  ----------------  --------  ---------------- 
Cash and cash 
 equivalents at 
 the  beginning of 
 period               77,100    76,493            75,105    76,493            67,284 
                    --------  --------  ----------------  --------  ---------------- 
Cash and cash 
 equivalents at 
 the end  of 
 period               72,785    77,100            66,173    72,785            66,173 
                    --------  --------  ----------------  --------  ---------------- 
 
 
([1]) All financial information presented in this press release is unaudited, 
consolidated and prepared in accordance with Taiwan-IFRS (International 
Financial Reporting Standards as endorsed for use in the R.O.C.). Such 
financial information is generated internally by us and has not been subjected 
to the same review and scrutiny, including internal auditing procedures and 
audit by our independent auditors, to which we subject our year-end audited 
consolidated financial statements, and may vary materially from the year-end 
audited consolidated financial information for the same period. Any evaluation 
of the financial information presented in this press release should also take 
into account our published year-end audited consolidated financial statements 
and the notes to those statements. In addition, the financial information 
presented is not necessarily indicative of our results of operations for any 
future period. 
([2]) EBITDA stands for net income or loss before interest, taxes, 
depreciation, amortization, impairment and investment gain or loss as well as 
other items. 
([3]) Borrowings include bank loans and bills payable. 
 

Investor Relations Contact

ir@aseglobal.com

Tel: +886.2.6636.5678

https://www.aseglobal.com

View original content:https://www.prnewswire.com/news-releases/ase-technology-holding-co-ltd-reports-its-unaudited-consolidated-financial-results-for-the-second-quarter-of-2025-302518315.html

SOURCE ASE Technology Holding Co., Ltd.

Seven-Site Pilot Spanning Pharma, Facility Management, Energy and Utilities to Validate AI Nose as Next-Gen Industrial AI at Scale

Robots Gain a New Sense: AI Nose Leverages Smell Language Model for Smart Scent Analytics

SAN DIEGO, CALIFORNIA / ACCESS Newswire / July 22, 2025 / Ainos, Inc. ("Ainos" or the "Company"), a leader in AI-driven scent digitization, today announced that ugo, Inc. ("ugo"), its first robotic partner, will pilot-deploy the world's first service robots equipped with a sense of smell powered by AI Nose at seven sites across Japan.

These robots, now empowered with a new sensory modality, will operate in pharmaceutical manufacturing, facility management, energy operations, power substations, and water treatment plants, at sites operated by leading Japanese corporations. This marks a historic milestone in robotic perception, blending olfactory sensing with industrial AI.

"This is a big step forward in the age of sensory AI," said Eddy Tsai, Chairman, President, and CEO of Ainos. "By giving robots the sense of smell, we are redefining how machines perceive and respond to the world. The pilot program is a great start to our 90-day roadmap. It positions us for large-scale rollout and SmellTech-as-a-Service commercialization in 2026."

As a leading service robot company in Japan, ugo's robots are already deployed in airports, data centers, factories, and corporate campuses across Japan. ugo robots with AI Nose will enable intelligent facility inspection, predictive maintenance, and environmental alerts, leveraging Ainos' proprietary smell language model (SLM) and Smell ID data insights.

"We are very honored. This is a major validation of our SmellTech model and represents strong interest from leading Japanese corporates across pharmaceuticals, energy, smart infrastructure, and utilities, each representing a high-value industrial vertical," said Mr. Eddy Tsai. "To be trusted by leading Japanese enterprises for this pilot program is a testament to the reliability and value of AI Nose. Investors should see this as a sign of strong progress, long-term scalability, and the credibility of our execution."

These seven-site pilots shortly follow Ainos and ugo's completed software and hardware integration, underscoring Ainos' execution and growing industrial momentum. Over the past few months, Ainos has secured strategic partnerships with ASE Technology Holding, Kenmec Mechanical Engineering Co., Ltd., and Solomon Technology Corporation to deploy AI Nose in semiconductor, automation, and smart-factory environments.

Ainos is fully committed to its 90-day action plan to accelerate growth and enhance long-term shareholder value. Today's pilot launch represents a major execution milestone. As part of the 90-day plan, Ainos also plans to complete pilot deployment of approximately 1,400 AI Nose units with ASE and kick off Phase 1 expansion to approximately 5,000 units.

In prior validations, AI Nose delivered approximately 80% accuracy across 22 industrial scent types at Japanese semiconductor facilities and achieved approximately 85% accuracy in hygiene-focused senior care pilots in Japan. In consumer evaluations, Smell ID has surpassed 90% accuracy on food and beverage scents. Insights from the ugo deployments will further optimize the platform and pave the way for a global rollout in 2026.

The global electronic nose market is projected to grow from USD 29.79 billion in 2025 to USD 76.45 billion by 2032, with industrial applications representing the largest demand segment. Japan is a pivotal launchpad for Ainos' robotic project as it ranks second in global robot deployment.

As part of Ainos' SmellTech-as-a-Service model, customers will gain access to subscription-based scent analytics, predictive alerts, and digital Smell ID profiles, turning previously invisible scent signals into actionable, revenue-generating intelligence.

About AI Nose

AI Nose digitizes scent into Smell ID, an AI-driven scent intelligence. This full-stack electronic nose (e-nose) platform combines precision MEMS sensor arrays with proprietary AI algorithms, aiming to detect scent at parts-per-billion (ppb) sensitivity. Smell ID then converts analog scent data into actionable insights, while the proprietary smell language model (SLM) learns complex scent patterns. Backed by a 13-year scent data moat and deep medtech expertise, AI Nose aims to deliver continuous monitoring, predictive analytics, and instant alerts to boost safety, quality, and efficiency. To be delivered as SmellTech-as-a-Service, it aims to offer subscription access to ongoing scent intelligence, analytics, and real-time alerts, turning the invisible into strategic advantage.

About Ainos, Inc.

Ainos, Inc. is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its AI Nose platform and smell language model (SLM) digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA®, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. Ainos, a fusion of "AI" and "Nose," is redefining machine perception for the sensory age. To learn more, visit https://www.ainos.com. Follow Ainos on X, formerly known as Twitter, (@AinosInc) and LinkedIn to stay up-to-date.

About ugo, Inc.

ugo, Inc. is a Japanese robotics manufacturer that specializes in business DX robots that combine remote operation and automatic control via AI. They are designed to flexibly respond to different facilities and tasks at each site, such as security, inspection, and guidance. In business areas where labor shortages are serious, ugo supports the continuity and efficiency of operations, as well as the realization of digital transformation, not as a replacement for people but as a "partner that works with people." To lean more, visit https://corp.ugo.plus.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are forward-looking statements. Forward-looking statements are based on management's current assumptions and expectations of future events and trends, which affect or may affect the Company's business, strategy, operations or financial performance, and actual results and other events may differ materially from those expressed or implied in such statements due to numerous risks and uncertainties. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. There are a number of important factors that could cause actual results, developments, business decisions or other events to differ materially from those contemplated by the forward-looking statements in this press release. These factors include, among other things, our expectation that we will incur net losses for the foreseeable future; our ability to become profitable; our ability to raise additional capital to continue our product development; our ability to accurately predict our future operating results; our ability to advance our current or future product candidates through clinical trials, obtain marketing approval and ultimately commercialize any product candidates we develop; the ability to obtain and maintain regulatory approval of our product candidates; delays in completing the development and commercialization of our current and future product candidates; developing and commercializing additional products, including diagnostic testing devices; our ability to compete in the marketplace; compliance with applicable laws, regulations and tariffs, and factors described in the Risk Factors section of our public filings with the Securities and Exchange Commission (SEC). Because forward-looking statements are inherently subject to risks and uncertainties, you should not rely on these forward-looking statements as predictions of future events. These forward-looking statements speak only as of the date of this press release and, except to the extent required by applicable law, the Company undertakes no obligation to update or revise these statements, whether as a result of any new information, future events and developments or otherwise.

Contact Information

Feifei Shen

ir@ainos.com

SOURCE: Ainos, Inc.

View the original press release on ACCESS Newswire

Commercial Momentum Accelerates with Partnerships to Drive AI-Powered Scent Intelligence for IndustrialAI and HealthcareAI

SAN DIEGO, CALIFORNIA / ACCESS Newswire / July 16, 2025 / Ainos, Inc. ("Ainos" or the "Company"), a pioneer in AI-powered scent digitization, today announced it has regained compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market. The compliance confirmation comes as Ainos gains momentum across its AI Nose platform, with strategic deployments, commercial partnerships, and a 90-day execution plan aimed at enabling large-scale commercialization by 2026.

"Over the past six months, we optimized our capital structure and delivered key milestones for the AI Nose platform, powered by our proprietary smell language model (SLM). We are positioning for a phase of accelerated deployment and scalable revenue generation across industrial, robotics, and healthcare sectors," said Eddy Tsai, Chairman and CEO of Ainos.

Recent AI Nose Milestones Driving Growth

• Strategic partnership with ASE Technology Holding (ASEH), the world's largest semiconductor packaging and testing company, with a targeted phased deployment plan of up to 15,000 AI Nose units.

• Expanded industrial footprint through partnerships with Kenmec and Solomon, aiming to integrate AI-powered scent intelligence powered by AI Nose and smell language model (SLM) into smart factory and machine vision ecosystems across Asia.

• Completed the world's first integration of AI Nose with a humanoid robot, for embedding digital olfactory sensing capabilities into ugo Inc.'s service robotics platform.

• Smell language model (SLM) surpassed 90% accuracy in classifying everyday scents, including meat, food, and beverages.

• Senior care program improved accuracy to ~85% from ~80%.

• 412% year-over-year revenue increase in Q1 2025, driven by initial AI Nose sales for the senior care program.

Key Strategic Priorities for the Next 90 Days

Building toward its 2026 scale-up, Ainos will focus on the following near-term priorities:

• Complete pilot deployment of approximately 1,400 AI Nose units with ASEH and initiate Phase 1 expansion to approximately 5,000 units.

• With Kenmec, exhibit the AI Nose integrated ugo robot at Automation Taipei, to be held August 20-23 in Taiwan.

• Drive SmellTech-as-a-Service (SaaS) as a subscription-based revenue model for AI Nose deployments and Smell ID services.

• Enhance SLM performance through broad-scale validation and expanded real-world testing.

• Pursue additional strategic partnerships in Asia and Europe for technology licensing and regional commercialization.

"Regaining Nasdaq compliance is just the beginning," Tsai added. "Our mission is to build a scalable, multi-revenue platform powered by scent intelligence, transforming smell into computable, actionable business data across global markets. I believe smell will be AI's next token."

On July 15, 2025, the Company received formal notice (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq") confirming that Ainos' common stock maintained a closing bid price of $1.00 or higher for ten consecutive business days, from June 30, 2025 to July 14, 2025. According to the Notice, the Company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2), and this matter is now officially closed.

About Ainos, Inc.

Ainos, Inc. is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its AI Nose platform and smell language model (SLM) digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA®, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. Ainos, a fusion of "AI" and "Nose," is redefining machine perception for the sensory age. To learn more, visit https://www.ainos.com. Follow Ainos on X, formerly known as Twitter, (@AinosInc) and LinkedIn to stay up-to-date.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are forward-looking statements. Forward-looking statements are based on management's current assumptions and expectations of future events and trends, which affect or may affect the Company's business, strategy, operations or financial performance, and actual results and other events may differ materially from those expressed or implied in such statements due to numerous risks and uncertainties. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. There are a number of important factors that could cause actual results, developments, business decisions or other events to differ materially from those contemplated by the forward-looking statements in this press release. These factors include, among other things, our expectation that we will incur net losses for the foreseeable future; our ability to become profitable; our ability to raise additional capital to continue our product development; our ability to accurately predict our future operating results; our ability to advance our current or future product candidates through clinical trials, obtain marketing approval and ultimately commercialize any product candidates we develop; the ability to obtain and maintain regulatory approval of our product candidates; delays in completing the development and commercialization of our current and future product candidates; developing and commercializing additional products, including diagnostic testing devices; our ability to compete in the marketplace; compliance with applicable laws, regulations and tariffs, and factors described in the Risk Factors section of our public filings with the Securities and Exchange Commission (SEC). Because forward-looking statements are inherently subject to risks and uncertainties, you should not rely on these forward-looking statements as predictions of future events. These forward-looking statements speak only as of the date of this press release and, except to the extent required by applicable law, the Company undertakes no obligation to update or revise these statements, whether as a result of any new information, future events and developments or otherwise.

Contact Information

Feifei Shen

ir@ainos.com

SOURCE: Ainos, Inc.

View the original press release on ACCESS Newswire

ASE Technology's unit, Siliconware Precision Industries, signed facility engineering contracts worth NT$689.9 million with Chung Yuang Electrical Consulting, according to a Monday Taiwan Exchange filing.

Shares gained 1% in the recent trading session on Tuesday.

The deals, which run from July 3, 2025, to Sept. 30, 2026, will support Siliconware Precision Industries' production and operational needs, the company said.